Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 4,54 MB, PDF-dokument
Metanephric Adenoma (MA) is a rare and unclassifiable renal tumour with sparse reported clinical and morphological features. Generally MA's have a benign course without recurrence after nephrectomy, however a few cases received oncological treatment due to malignant progression. We present a 42-year-old woman who years after an initial nephrectomy developed several processes and biopsy confirmed recurrence of MA. Sunitinib was given for only two weeks, as she developed side-effects and currently the patient undergoes control scans with only minimal growth of the processes. This is the first case of MA treated with Tyrosin-Kinase-Inhibitor.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 101880 |
Tidsskrift | Urology Case Reports |
Vol/bind | 40 |
Antal sider | 4 |
ISSN | 2214-4420 |
DOI | |
Status | Udgivet - 2022 |
ID: 290109540